title: Insulin-like growth factor (IGF)-I levels in postmenopausal women receiving tibolone.
authors.affiliation: Department of Obstetrics and Gynaecology, Guy's Hospital, London, United Kingdom.
authors.forename: K D
authors.initials: KD
authors.lastname: Hopkins
authors.forename: J R
authors.initials: JR
authors.lastname: Parker
authors.forename: E D
authors.initials: ED
authors.lastname: Lehmann
authors.forename: J
authors.initials: J
authors.lastname: Rymer
authors.forename: J M
authors.initials: JM
authors.lastname: Holly
authors.forename: I
authors.initials: I
authors.lastname: Fogelman
authors.forename: S
authors.initials: S
authors.lastname: Cwyfan-Hughes
authors.forename: J D
authors.initials: JD
authors.lastname: Teale
authors.forename: R G
authors.initials: RG
authors.lastname: Gosling
mesh_terms: D045930:Anabolic Agents; D015914:Estrogen Replacement Therapy; D005260:Female; D006801:Humans; D007334:Insulin-Like Growth Factor I / Q000378:metabolism*; D008875:Middle Aged; D009652:Norpregnenes / Q000008:administration & dosage / Q000009:adverse effects* / Q000627:therapeutic use*; D017698:Postmenopause / Q000097:blood*
chemical_list: D045930:Anabolic Agents; D009652:Norpregnenes; D007334:Insulin-Like Growth Factor I; C027385:tibolone